Evaluate the PK of LY03010 Process 1 and Process 2 Drug Product vs INVEGA SUSTENNA After Intramuscular Injection in Schizophrenia Patients

NCT04572685 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia Patients

Interventions

DRUG: Paliperidone Palmitate

Sponsor

Luye Pharma Group Ltd.

Collaborators

[object Object]
[object Object]